Dexmedetomidine and Outcomes of Cardiac Surgery (DOCS)
A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1100 participants.
Also called NCT02237495
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose prevention
- Phase
- Phase 2/3
- Enrolled
- 1,100 participants
- Sponsor
- Registry
-
NCT02237495
-
- Other papers using this trial's data
- Effects of Dexmedetomidine on Outcomes After Cardiac Surgery (DOCS): a randomised double-blind, placebo-controlled trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT02237495. Randomized; double masking; primary purpose prevention. Start 2014-04-09 (actual); primary completion 2017-03-01 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Dexmedetomidine and Outcomes of Cardiac Surgery (DOCS)
- Acronym
- DOCS
- Condition
- Heart Valve Diseases
- Condition
- Coronary Artery Disease
- Intervention (Drug)
- dexmedetomidine
- Intervention (Drug)
- placebo
- Lead sponsor
- Xijing Hospital
Record details
- Record id
cardio:ct-nct02237495- Content hash
ea0883adaa4f1ac9002ed2a6c6e04a6c2aedefc6e1eb51e248c1541200bb6dc6